These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24448555)

  • 1. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
    Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
    Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ
    Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrosulfide Adducts of Organo-Iridium Anticancer Complexes.
    Štarha P; Habtemariam A; Romero-Canelón I; Clarkson GJ; Sadler PJ
    Inorg Chem; 2016 Mar; 55(5):2324-31. PubMed ID: 26863200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
    De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor Effects of Ir(III)-2
    Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
    Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.
    Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z
    Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Ir-N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes.
    Carrasco AC; Rodríguez-Fanjul V; Pizarro AM
    Inorg Chem; 2020 Nov; 59(22):16454-16466. PubMed ID: 33103884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.
    Pettinari R; Marchetti F; Pettinari C; Condello F; Petrini A; Scopelliti R; Riedel T; Dyson PJ
    Dalton Trans; 2015 Dec; 44(47):20523-31. PubMed ID: 26548708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.
    Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z
    Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organometallic half-sandwich iridium anticancer complexes.
    Liu Z; Habtemariam A; Pizarro AM; Fletcher SA; Kisova A; Vrana O; Salassa L; Bruijnincx PC; Clarkson GJ; Brabec V; Sadler PJ
    J Med Chem; 2011 Apr; 54(8):3011-26. PubMed ID: 21443199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoiridium complexes: anticancer agents and catalysts.
    Liu Z; Sadler PJ
    Acc Chem Res; 2014 Apr; 47(4):1174-85. PubMed ID: 24555658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies.
    Kong D; Tian M; Guo L; Liu X; Zhang S; Song Y; Meng X; Wu S; Zhang L; Liu Z
    J Biol Inorg Chem; 2018 Jul; 23(5):819-832. PubMed ID: 29934699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.
    Ruiz J; Rodríguez V; Cutillas N; Samper KG; Capdevila M; Palacios Ò; Espinosa A
    Dalton Trans; 2012 Nov; 41(41):12847-56. PubMed ID: 22983366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.